143 related articles for article (PubMed ID: 28499879)
1. Developing a Flexible Pediatric Dosage Form for Antiretroviral Therapy: A Fast-Dissolving Tablet.
Lal M; Lai M; Estrada M; Zhu C
J Pharm Sci; 2017 Aug; 106(8):2173-2177. PubMed ID: 28499879
[TBL] [Abstract][Full Text] [Related]
2. Development of a fast-dissolving tablet formulation of a live attenuated enterotoxigenic E. coli vaccine candidate.
Lal M; Priddy S; Bourgeois L; Walker R; Pebley W; Brown J; Desai J; Darsley MJ; Kristensen D; Chen D
Vaccine; 2013 Oct; 31(42):4759-64. PubMed ID: 23965220
[TBL] [Abstract][Full Text] [Related]
3. Development and in vivo evaluation of child-friendly lopinavir/ritonavir pediatric granules utilizing novel in situ self-assembly nanoparticles.
Pham K; Li D; Guo S; Penzak S; Dong X
J Control Release; 2016 Mar; 226():88-97. PubMed ID: 26849919
[TBL] [Abstract][Full Text] [Related]
4. Soluplus
Basha M; Salama A; Noshi SH
Drug Dev Ind Pharm; 2020 Feb; 46(2):253-263. PubMed ID: 31937139
[TBL] [Abstract][Full Text] [Related]
5. A Pilot Stability Study of Dehydroepiandrosterone Rapid-dissolving Tablets Prepared by Extemporaneous Compounding.
Rush SD; Vernak C; Zhao F
Int J Pharm Compd; 2017; 21(1):83-87. PubMed ID: 28346201
[TBL] [Abstract][Full Text] [Related]
6. The Palatability of Lopinavir and Ritonavir Delivered by an Innovative Freeze-Dried Fast-Dissolving Tablet Formulation.
Pittman DW; Brantly AM; Drobonick AL; King HT; Mesta DC; Richards CG; Lal M; Lai M
AIDS Res Treat; 2018; 2018():5908167. PubMed ID: 29593900
[TBL] [Abstract][Full Text] [Related]
7. Development of Oral Flexible Tablet (OFT) Formulation for Pediatric and Geriatric Patients: a Novel Age-Appropriate Formulation Platform.
Chandrasekaran P; Kandasamy R
AAPS PharmSciTech; 2017 Aug; 18(6):1972-1986. PubMed ID: 27921260
[TBL] [Abstract][Full Text] [Related]
8. Fast disintegrating tablets: Opportunity in drug delivery system.
Parkash V; Maan S; Deepika ; Yadav SK; Hemlata ; Jogpal V
J Adv Pharm Technol Res; 2011 Oct; 2(4):223-35. PubMed ID: 22247889
[TBL] [Abstract][Full Text] [Related]
9. Alternative Manufacturing Concepts for Solid Oral Dosage Forms From Drug Nanosuspensions Using Fluid Dispensing and Forced Drying Technology.
Bonhoeffer B; Kwade A; Juhnke M
J Pharm Sci; 2018 Mar; 107(3):909-921. PubMed ID: 29154900
[TBL] [Abstract][Full Text] [Related]
10. Development of a Vaginal Fast-Dissolving Insert Combining Griffithsin and Carrageenan for Potential Use Against Sexually Transmitted Infections.
Lal M; Lai M; Ugaonkar S; Wesenberg A; Kizima L; Rodriguez A; Levendosky K; Mizenina O; Fernández-Romero J; Zydowsky T
J Pharm Sci; 2018 Oct; 107(10):2601-2610. PubMed ID: 29902477
[TBL] [Abstract][Full Text] [Related]
11. Amorphous Formulation and in Vitro Performance Testing of Instantly Disintegrating Buccal Tablets for the Emergency Delivery of Naloxone.
Alqurshi A; Kumar Z; McDonald R; Strang J; Buanz A; Ahmed S; Allen E; Cameron P; Rickard JA; Sandhu V; Holt C; Stansfield R; Taylor D; Forbes B; Royall PG
Mol Pharm; 2016 May; 13(5):1688-98. PubMed ID: 26977787
[TBL] [Abstract][Full Text] [Related]
12. Safe, swallowable and palatable paediatric mini-tablet formulations for a WHO model list of essential medicines for children compound - A promising starting point for future PUMA applications.
Freerks L; Sommerfeldt J; Löper PC; Klein S
Eur J Pharm Biopharm; 2020 Nov; 156():11-19. PubMed ID: 32871197
[TBL] [Abstract][Full Text] [Related]
13. Powder for reconstitution of the anti-HIV-1 drug TMC278 - Formulation development, stability and animal studies.
Van Gyseghem E; Pendela M; Baert L; Rosier J; Van 't Klooster G; De Man H; Bouche MP; Schueller L; Van Remoortere P; Wigerinck P; Adams E; Hoogmartens J; Van den Mooter G
Eur J Pharm Biopharm; 2008 Nov; 70(3):853-60. PubMed ID: 18657611
[TBL] [Abstract][Full Text] [Related]
14. Application of co-processed excipients for developing fast disintegrating tablets: A review.
Jain S; Kaur S; Rathi R; Nagaich U; Singh I
Polim Med; 2023; 53(1):59-68. PubMed ID: 36929642
[TBL] [Abstract][Full Text] [Related]
15. Formulation, preparation, and evaluation of novel orally disintegrating tablets containing taste-masked naproxen sodium granules and naratriptan hydrochloride.
Stange U; Führling C; Gieseler H
J Pharm Sci; 2014 Apr; 103(4):1233-45. PubMed ID: 24532095
[TBL] [Abstract][Full Text] [Related]
16. Development of a low-dose fast-dissolving tablet formulation of Newcastle disease vaccine for low-cost backyard poultry immunisation.
Lal M; Zhu C; McClurkan C; Koelle DM; Miller P; Afonso C; Donadeu M; Dungu B; Chen D
Vet Rec; 2014 May; 174(20):504. PubMed ID: 24591479
[TBL] [Abstract][Full Text] [Related]
17. Feasability of a new process to produce fast disintegrating pellets as novel multiparticulate dosage form for pediatric use.
Hoang Thi TH; Lhafidi S; Carneiro SP; Flament MP
Int J Pharm; 2015 Dec; 496(2):842-9. PubMed ID: 26403385
[TBL] [Abstract][Full Text] [Related]
18. Preparation and optimization of fast disintegrating tablets of isosorbide dinitrate using lyophilization method for oral drug delivery.
Alami-Milani M; Salatin S; Nasiri E; Jelvehgari M
Ther Deliv; 2021 Jul; 12(7):523-538. PubMed ID: 34098729
[No Abstract] [Full Text] [Related]
19. The relevance of co-amorphous formulations to develop supersaturated dosage forms: In-vitro, and ex-vivo investigation of Ritonavir-Lopinavir co-amorphous materials.
Sai Krishna Anand V; Sakhare SD; Navya Sree KS; Nair AR; Raghava Varma K; Gourishetti K; Dengale SJ
Eur J Pharm Sci; 2018 Oct; 123():124-134. PubMed ID: 30048798
[TBL] [Abstract][Full Text] [Related]
20. The physical characteristics of lyophilized tablets containing a model drug in different chemical forms and concentrations.
Sznitowska M; Płaczek M; Klunder M
Acta Pol Pharm; 2005; 62(1):25-9. PubMed ID: 16022490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
